Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin in Multiple Sclerosis
IRCT20171220037977N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in multiple sclerosis (MS), sponsored by Isfahan University of Medical Sciences. Started Feb 2018; status: completed.
02
Drugs
silymarin
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20171220037977N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171220037977N1.